|
The Anti-tumor Activity of Chinese Medical Prescription JC-001
演題番号 : ISP-2
Meng-Hsien Chuang:1、Ming-Shiou Jan:2,3、Li-Jun Hsu:4、Jinghua Tsai Chang:1、Fung-Jou Lu:1
1:Institute of Medicine, Chung Shan Medical University, China、2:Department of Microbiology and Immunology, Chung Shan Medical University, China、3:Immunology and Rheumatology, Department of Internal Medicine, Chung-Shan Medical University Hospital, China、4:Department of Medical Laboratory Science and Technology, National Cheng Kung University, China
|
|
|
|
Antitumor effects of an herbal prescription JC001
演題番号 : ISP-3
Ming-Shiou Jan:1,2、Shu-Han Chuang:1、You-Chain Lin:1、Meng-Hsien Chuang:3、Yu-Ying Lin:3、Yu-Pu Hsia:4、Jinghua Tsai Chang:3、Li-Jun Hsu:5
1:Institute of Microbiology and Immunology, Chung Shan Medical University, Taiwan、2:Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taiwan、3:Institute of Medicine, Medical College, Chung Shan Medical University, Taiwan、4:Department of Microbiology and Immunology, Medical College, National Cheng Kung University, Taiwan、5:Department of Medical Laboratory Science and Biotechnology, Medical College, National Cheng Kung University, Taiwan
|
|
|
|
Results of chemotherapy in the patients with metastatic or recurrent HNSCC
演題番号 : ISP-6
Hunho Song:1、Hyo Jung Kim:2、Geundoo Jang:1、Jung Hye Kwon:1、Boram Han:2、Jung Han Kim:4、Hyeong Su Kim:4、Dae Ro Choi:3
1:Internal Medicine/Hemato-oncology, Kangdong Sacred Heart Hospital, College of Medicine, Hallym Univ., Korea、2:Internal Medicine/Hemato-oncology, Hallym Sacred Heart Hospital, College of Medicine, Hallym Univ., Korea、3:Internal Medicine, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym Univ., Korea、4:Internal Medicine/Hemato-oncology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym Univ., Korea
|
|
|
|
Cost analysis of S1 and XELOX as adjuvant therapy for gastric cancer
演題番号 : ISP-10
Wen Feng:1、He Jianping:1、Yin Xude:2、Zhang Pengfei:1、Du Zedong:3、He Xiaofeng:4、Zhou Yi:1、Tang Ruilei:1、Li Meng:1、Li Qiu:1
1:Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, China、2:The Department of Medical Oncology, Sichuan Cancer Hospital, China、3:The Department of Oncology, 363 Hospital, China、4:The Department of Medical Oncology, First People's Hospital of Longquanyi District, China
|
|
|
|
Pharmacokinetics and safety of pertuzumab in HER2-positive gastric cancer
演題番号 : ISP-14
Yoon-Koo Kang:1、Sun Young Rha:2、Pierfrancesco Tassone:3、Jorge Barriuso:4、Ron Yu:5、Tania Szado:5、Amit Garg:5、Yung-Jue Bang:6
1:Asan Medical Center, University of Ulsan, Korea、2:Yonsei Cancer Center, Yonsei University College of Medicine, Korea、3:Medical Oncology Unit, Magna Graecia University, Italy、4:Hospital Universitario La Paz, Spain、5:Genentech, USA、6:Seoul National University Hospital, Korea
|
|
|
|
A survey of MET overexpression and amplification in hepatocellular carcinoma
演題番号 : ISP-18
Ho Yeong Lim:1、Sujin Lee:1、Jeeyun Lee:1、Cheol-Keun Park:1、Insuk Sohn:1,2、Mao Mao:3、Wang Kai:3
1:Departments of Internal Medicine and Pathology, Samsung Medical Center, Sungkyunkwan University, Korea、2:Samsung Genomic Center, Samsung Medical Center, Korea、3:Oncology Research Unit, Pfizer Inc., USA
|
|
|
|
The Role of miR-1 in the Progression of Gastrointestinal Stromal Tumors
演題番号 : ISP-21
Han-Chen Lin:1、Tsai-Kun Lee:2、Chia-Chin Tsai:1、Tang-Long Sheng:3、I-Rue Lai:1,4
1:Department of Anatomy and Cell Biology1, Medical College, National Taiwan University, Taiwan、2:Graduate Institute of Microbiology, Medical College, National Taiwan University, Taiwan、3:Department of Plant Pathology and Microbiology, National Taiwan University, Taiwan、4:Department of Surgery, National Taiwan University Hospital4, Taiwan
|
|
|
|
Survival and the Extent of Metastases in Advanced Non-squamous NSCLC
演題番号 : ISP-25
Dong Soo Lee:1、Jin Hyoung Kang:2、Chang Geol Lee:3、Seoung Jun Kim:4、Young Jin Choi:5、Kyo Young Lee:5、Yeon Sil Kim:1
1:Department of Radiation Oncology, Seoul St. Mary's Hospital, Korea、2:Department of Medical Oncology, Seoul St. Mary's Hospital, Korea、3:Department of Radiation Oncology, Severance Hospital, Korea、4:Department of Internal Medicine, Seoul St. Mary's Hospital, Korea、5:Department of Pathology, Seoul St. Mary's Hospital, Korea
|
|
|
|
The long-term follow up of the RFA for the early breast cancer
演題番号 : ISP-26
Tomomi Fujisawa:1、Takeshi Miyamoto:1、Yasuhiro Yanagita:1、Tomoko Hirakata:2、Ritsuko Tsukagoshi:3
1:Department of Breastoncology, Gunma Prefectural Cancer Center, Japan、2:Isesaki community hospital, department of surgery, Japan、3:Tone-chuo-hospital, Japan
|
|
|
|
Comparison of 3 methods of assessing anxiety and depression during radiotherapy
演題番号 : ISP-29
Lisa J Mackenzie:1,2、Eiji Suzuki:3、Masakazu Ogura:4、Mariko Carey:1、Rob Sanson-Fisher:2、Hiromi Asada:5、Masakazu Toi:3、Masahiro Hiraoka:4、Catherine D'Este:1
1:School of Medicine & Public Health, The University of Newcastle, Australia、2:Graduate School of Medicine, Kyoto University Hospital, Japan、3:Breast Surgery, Kyoto University Hospital, Japan、4:Radiation Oncology & Image-applied Therapy, Kyoto University Hospital, Japan、5:Department of Nursing, Kyoto University Hospital, Japan
|
|
|
|
Characteristics of APCU patients admitted from the Emergency Center
演題番号 : ISP-30
Seong Hoon Shin:1、Eduardo Bruera:2、David Hui:2、Gary B Chisholm:2、Jung Hye Kwon:3、San-Miguel T Maria:4、Allo A Julio:2、Sriram Yennurajalingam:2、Susan E Frisbee-Hume :2
1:Department of Internal Medicine, College of Medicine, Kosin University, Busan, Korea、2:Department of Palliative Care and Rehabilitation Medicine, MD Anderson Cancer Center, USA、3:Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University, Chuncheon, Korea、4:Department of Palliative Medicine, Clinica Universidad de Navarra, Spain
|
|
|
|
